Immunoreactivity of the 14F7 Mab (Raised against N-Glycolyl GM3 Ganglioside) as a Positive Prognostic Factor in Non-Small-Cell Lung Cancer.
about
Ganglioside biochemistryTissue Reactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Tumors of Neuroectodermal, Mesodermal, and Epithelial Origin.Prognostic Significance of N-Glycolyl GM3 Ganglioside Expression in Non-Small Cell Lung Carcinoma Patients: New Evidences.Preclinical evaluation of racotumomab, an anti-idiotype monoclonal antibody to N-glycolyl-containing gangliosides, with or without chemotherapy in a mouse model of non-small cell lung cancer.Anti-ganglioside antibodies induced in chickens by an alum-adsorbed anti-idiotype antibody targeting NeuGcGM3.Immunoreactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Primary Lymphoid Tumors and Lymph Node Metastasis.Involvement of a non-human sialic Acid in human cancer.Prognostic Role of 14F7 Mab Immunoreactivity against N-Glycolyl GM3 Ganglioside in Colon Cancer.Sphingolipids: key regulators of apoptosis and pivotal players in cancer drug resistancePilot study of a novel combination of two therapeutic vaccines in advanced non-small-cell lung cancer patients.Tumor Expression of the Carcinoembryonic Antigen Correlates with High Mitotic Activity and Cell Pleomorphism Index in Lung CarcinomaTissue Expression of Low and High Molecular Weight Cytokeratins in Lung Carcinoma Sections: Its Correlation with Some Clinic-Pathological Features
P2860
Q35361488-C7A32126-5F65-435B-B4D7-1CF729E8ADAAQ35623519-ECA05272-B378-459A-9391-0C70E5DC66E0Q36304631-C4FC5A1F-BD88-405F-89FE-5A2B356935A1Q36382557-645E119C-1779-4A31-A719-0BAFC3B0A28BQ36540352-3271F953-452A-41CF-A74C-E29E61F67711Q37393097-C52261B2-01A4-4838-A05F-9EBAF2317358Q37592596-87E65A21-FB63-43E2-A6E3-B9621605E6F3Q37594945-A536F05F-3956-4B4E-913B-46ADEF7F9A18Q38195691-244486A5-16CF-4722-8B07-9F8F08C1A521Q38207923-05574B21-625F-4D90-908E-890175CE3B60Q58920169-CFC7DEA5-E816-40AD-8F75-B4DD49535BA1Q59051092-D0E168DE-BC98-4DAC-A768-EDC5C6FBE0B9
P2860
Immunoreactivity of the 14F7 Mab (Raised against N-Glycolyl GM3 Ganglioside) as a Positive Prognostic Factor in Non-Small-Cell Lung Cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Immunoreactivity of the 14F7 M ...... in Non-Small-Cell Lung Cancer.
@en
Immunoreactivity of the 14F7 Mab
@nl
type
label
Immunoreactivity of the 14F7 M ...... in Non-Small-Cell Lung Cancer.
@en
Immunoreactivity of the 14F7 Mab
@nl
prefLabel
Immunoreactivity of the 14F7 M ...... in Non-Small-Cell Lung Cancer.
@en
Immunoreactivity of the 14F7 Mab
@nl
P2093
P2860
P356
P1476
Immunoreactivity of the 14F7 M ...... in Non-Small-Cell Lung Cancer
@en
P2093
Adriana Carr
Charles E Rengifo
Enrique Rengifo
Mercedes Cedeño
Milagros Frómeta
P2860
P304
P356
10.1155/2012/235418
P577
2012-02-26T00:00:00Z